Cargando…

Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer’s disease

BACKGROUND: Immunologic abnormalities have been described in peripheral blood and central nervous system of patients suffering from Alzheimer’s disease (AD), yet their role in the pathogenesis still remains poorly defined. AIM AND METHODS: We used the triple transgenic mouse model (3xTg-AD) to repro...

Descripción completa

Detalles Bibliográficos
Autores principales:	St-Amour, Isabelle, Bosoi, Cristina R., Paré, Isabelle, Ignatius Arokia Doss, Prenitha Mercy, Rangachari, Manu, Hébert, Sébastien S., Bazin, Renée, Calon, Frédéric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320637/ https://www.ncbi.nlm.nih.gov/pubmed/30611289 http://dx.doi.org/10.1186/s12974-018-1380-5

Ejemplares similares

Interferon-β Suppresses Murine Th1 Cell Function in the Absence of Antigen-Presenting Cells
por: Boivin, Nicolas, et al.
Publicado: (2015)

The Non-Obese Diabetic Mouse Strain as a Model to Study CD8(+) T Cell Function in Relapsing and Progressive Multiple Sclerosis
por: Ignatius Arokia Doss, Prenitha Mercy, et al.
Publicado: (2015)

Endogenous T Cell Receptor Rearrangement Represses Aggressive Central Nervous System Autoimmunity in a TcR-Transgenic Model on the Non-Obese Diabetic Background
por: Yeola, Asmita Pradeep, et al.
Publicado: (2020)

IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology
por: St-Amour, Isabelle, et al.
Publicado: (2014)

Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson’s disease
por: St-Amour, Isabelle, et al.
Publicado: (2012)

A Scoping Review of Modifiable Risk Factors in Pediatric Onset Multiple Sclerosis: Building for the Future
por: Pétrin, Julie, et al.
Publicado: (2018)

High‐Fat Diet Modulates Hepatic Amyloid β and Cerebrosterol Metabolism in the Triple Transgenic Mouse Model of Alzheimer’s Disease
por: Bosoi, Cristina R., et al.
Publicado: (2020)

microRNA-132/212 deficiency enhances Aβ production and senile plaque deposition in Alzheimer’s disease triple transgenic mice
por: Hernandez-Rapp, Julia, et al.
Publicado: (2016)

Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer’s Disease, Without Altering Amyloid-β and Tau Pathologies
por: Fanet, Hortense, et al.
Publicado: (2021)

Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function
por: Delay, Charlotte, et al.
Publicado: (2011)

Effect of 50% Hydro-Ethanolic Leaf Extracts of Ruellia Tuberosa L. and Dipteracanthus Patulus (Jacq.) on Lipid Profile in Alloxan Induced Diabetic Rats
por: Ananthakrishnan, Manikandan, et al.
Publicado: (2013)

Identification of serum predictors of n-acetyl-l-cysteine and isoproterenol induced remodelling in cardiac hypertrophy
por: KUBERAPANDIAN, Dharaniyambigai, et al.
Publicado: (2021)

Repeated cold exposures protect a mouse model of Alzheimer's disease against cold-induced tau phosphorylation
por: Tournissac, Marine, et al.
Publicado: (2019)

Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease
por: Bories, Cyril, et al.
Publicado: (2017)

Specificity of Anti-Tau Antibodies when Analyzing Mice Models of Alzheimer's Disease: Problems and Solutions
por: Petry, Franck R., et al.
Publicado: (2014)

Widespread alterations in microRNA biogenesis in human Huntington’s disease putamen
por: Petry, Serena, et al.
Publicado: (2022)

Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease
por: Reveret, Louise, et al.
Publicado: (2023)

Higher Angiotensin I Converting Enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease
por: Louise, Reveret, et al.
Publicado: (2023)

Correction to: Higher angiotensin‑converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease
por: Reveret, Louise, et al.
Publicado: (2023)

Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice
por: Clavaguera, Florence, et al.
Publicado: (2013)

Advances and Challenges in Understanding MicroRNA Function in Tauopathies: A Case Study of miR-132/212
por: Boscher, Emmanuelle, et al.
Publicado: (2020)

Dendritic complexity change in the triple transgenic mouse model of Alzheimer’s disease
por: Zhang, Yu, et al.
Publicado: (2020)

Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer’s Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil
por: Killick, Richard, et al.
Publicado: (2023)

The Consortium for the early identification of Alzheimer's disease–Quebec (CIMA-Q)
por: Belleville, Sylvie, et al.
Publicado: (2019)

Preventive Effect of Quercetin in a Triple Transgenic Alzheimer’s Disease Mice Model
por: Paula, Pérez-Corredor, et al.
Publicado: (2019)

Hepato-renal protective effects of hydroethanolic extract of Senna alata on enzymatic and nonenzymatic antioxidant systems in streptozotocin induced diabetic rats
por: Sugumar, Mohanasundaram, et al.
Publicado: (2016)

A Triple-Transgenic Immunotolerant Mouse Model
por: Brenden, Nina, et al.
Publicado: (2013)

Multiple Events Lead to Dendritic Spine Loss in Triple Transgenic Alzheimer's Disease Mice
por: Bittner, Tobias, et al.
Publicado: (2010)

Staging of Alzheimer's Pathology in Triple Transgenic Mice: A Light and Electron Microscopic Analysis
por: Oh, Kwang-Jin, et al.
Publicado: (2010)

Impaired Satiation and Increased Feeding Behaviour in the Triple-Transgenic Alzheimer's Disease Mouse Model
por: Adebakin, Adedolapo, et al.
Publicado: (2012)

Impaired Adult Neurogenesis in the Dentate Gyrus of a Triple Transgenic Mouse Model of Alzheimer's Disease
por: Rodríguez, José J., et al.
Publicado: (2008)

Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease
por: Yeh, Chia-Yu, et al.
Publicado: (2011)

Age-Dependent Biochemical Dysfunction in Skeletal Muscle of Triple-Transgenic Mouse Model of Alzheimer`s Disease
por: Monteiro-Cardoso, Vera F., et al.
Publicado: (2015)

Redox Proteomic Profiling of Specifically Carbonylated Proteins in the Serum of Triple Transgenic Alzheimer’s Disease Mice
por: Shen, Liming, et al.
Publicado: (2016)

Selenomethionine Ameliorates Neuropathology in the Olfactory Bulb of a Triple Transgenic Mouse Model of Alzheimer’s Disease
por: Zhang, Zhong-Hao, et al.
Publicado: (2016)

The Protective Effects of Clams on Hypercholesterolemia in Late-Stage Triple-Transgenic Alzheimer’s Diseased Mice Hearts
por: Hsieh, You-Liang, et al.
Publicado: (2018)

Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer’s Disease
por: González de San Román, Estibaliz, et al.
Publicado: (2021)

Compromised Astrocyte Swelling/Volume Regulation in the Hippocampus of the Triple Transgenic Mouse Model of Alzheimer’s Disease
por: Tureckova, Jana, et al.
Publicado: (2022)

Compensatory remodeling of a septo-hippocampal GABAergic network in the triple transgenic Alzheimer’s mouse model
por: Wander, Connor M, et al.
Publicado: (2023)

Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives
por: Sahila, Mohammed Marunnan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bu7edtiuvhvf2p7nm671euhfte